Fibroblast growth factor-2 and -4 promote the proliferation of bone marrow mesenchymal stem cells by the activation of the PI3K-Akt and ERK1/2 signaling pathways

Stem Cells and Development

Volumn 17, Issue 4, 2008, Pages 725-736

  Choi, Seung Cheol ^a   Kim, Su Jin ^a   Choi, Ji Hyun ^a   Park, Chi Yeon ^a   Shim, Wan Joo ^a   Lim, Do Sun ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 MORPHOLINO 8 PHENYLCHROMONE; BROXURIDINE; CYTOKINE; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR 4; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN C JUN; PROTEIN KINASE B; STAT3 PROTEIN; STEM CELL ANTIGEN 1;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; ENZYME ACTIVATION; FEMALE; HEMATOPOIETIC STEM CELL; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; UPREGULATION; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; BONE MARROW CELLS; BUTADIENES; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMONES; ENZYME ACTIVATION; ENZYME INHIBITORS; FEMALE; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR 4; JANUS KINASE 2; MAP KINASE KINASE 1; MAP KINASE KINASE 2; MAP KINASE SIGNALING SYSTEM; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED ICR; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MORPHOLINES; NERVE TISSUE PROTEINS; NITRILES; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-JUN; STAT3 TRANSCRIPTION FACTOR; TIME FACTORS; UP-REGULATION;

EID: 51849111566     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2007.0230     Document Type: Article

References (68)

1. Pittenger MF, AM Mackay, SC Beck, RK Jaiswal, R Douglas, JD Mosca, MA Moorman, DW Simonetti, S Craig and DR Marshak. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
2. Ballas CB, SP Zielske and SL Gerson. (2002). Adult bone marrow stem cells for cell and gene therapies: implications for greater use. J Cell Biochem Suppl 200;38:20-28.
3. Reiser J, XY Zhang, CS Hemenway, D Mondal, L Pradhan and VF La Russa. (2005). Potential of mesenchymal stem cells in gene therapy approaches for inherited and acquired diseases. Expert Opin Biol Ther 5:1571-1584.
4. van de Rijn M, S Heimfeld, GJ Spangrude and IL Weissman. (1989). Mouse hematopoietic stem-cell antigen Sca-1 is a member of the Ly-6 antigen family. Proc Natl Acad Sci USA 86:4634-4638.
5. Qu-Petersen Z, B Deasy, R Jankowski, M Ikezawa, J Cummins, R Pruchnic, J Mytinger, B Cao, C Gates, A Wernig and J Huard. (2002). Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration. J Cell Biol 157:851-864.
6. Gojo S, N Gojo, Y Takeda, T Mori, H Abe, S Kyo, J Hata and A Umezawa. (2003). In vivo cardiovasculogenesis by direct injection of isolated adult mesenchymal stem cells. Exp Cell Res 288:51-59.
7. Matsuura K , T Nagai, N Nishigaki, T Oyama, J Nishi, H Wada, M Sano, H Toko, H Akazawa, T Sato, H Nakaya, H Kasanuki and I Komuro. (2004). Adult cardiac sca-1-positive cells differentiate into beating cardiomyocytes. J Biol Chem 279:11384-11391.
8. Burger PE, X Xiong, S Coetzee, SN Salm, D Moscatelli, K Goto and EL Wilson. (2005). Sca-1 expression identifies stem cells in the proximal region of prostatic ducts with high capacity to reconstitute prostatic tissue. Proc Natl Acad Sci USA 102:7180-7185.
9. Bonyadi M, SD Waldman, D Liu, JE Aubin, MD Grynpas and WL Stanford. (2003). Mesenchymal progenitor self-renewal deficiency leads to age-dependent osteoporosis in Sca-1/Ly-6A null mice. Proc Natl Acad Sci USA 100:5840-5845.
10. Holmes C, TS Khan, C Owen, N Ciliberti, MD Grynpas and WL Stanford. (2007). Longitudinal analysis of mesenchymal progenitors and bone quality in the stem cell antigen-1-null osteoporotic mouse. J Bone Miner Res 22:1373-1386.
11. Okada-Ban M, JP Thiery and J Jouanneau. (2000). Fibroblast growth factor-2. Int J Biochem Cell Biol 32:263-267.
12. Coumoul X and CX Deng. (2003). Roles of FGF receptors in mammalian development and congenital diseases Birth Defects Res C Embryo Today 69:286-304.
13. Eswarakumar VP, I Lax and J Schlessinger. (2005). Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev 16:139-149.
14. Craig CG, V Tropepe, CM Morshead, BA Reynolds, S Weiss and D van der Kooy. (1996). In vivo growth factor expansion of endogenous subependymal neural precursor cell populations in the adult mouse brain. J Neurosci 16:2649-2658.
15. Quito FL, J Beh, O Bashayan, C Basilico and RS Basch. Effects of fibroblast growth factor-4 (k-FGF) on long-term cultures of human bone marrow cells. Blood 1996;87:1282-1291.
16. Gritti A, P Frolichsthal-Schoeller, R Galli, EA Parati, L Cova, SF Pagano, CR Bjornson and AL Vescovi. (1999). Epidermal and fibroblast growth factors behave as mitogenic regulators for a single multipotent stem cell-like population from the subventricular region of the adult mouse forebrain. J Neurosci 19:328703297.
17. Bianchi G, A Banfi, M Mastrogiacomo, R Notaro, L Luzzatto, R Cancedda and R Quarto. (2003). Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2. Exp Cell Res 287:98-105.
18. Wang L, L Li, P Menendez, C Cerdan and M Bhatia. (2005). Human embryonic stem cells maintained in the absence of mouse embryonic fibroblasts or conditioned media are capable of hematopoietic development. Blood 105:4598-4603.
19. Yeoh JS, R van Os, E Weersing, A Ausema, B Dontje, E Vellenga and G de Haan. (2006). Fibroblast growth factor-1 and -2 preserve long-term repopulating ability of hematopoietic stem cells in serum-free cultures. Stem Cells 24:1564-1572.
20. Yeoh JS and G de Haan. (2007). Fibroblast growth factors as regulators of stem cell self-renewal and aging. Mech Ageing Dev 128:17-24.
21. Tsutsumi S, A Shimazu, K Miyazaki, H Pan, C Koike, E Yoshida, K Takagishi and Y Kato. (2001). Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF. Biochem Biophys Res Commun 288:413-419.
22. Baddoo M, K Hill, R Wilkinson, D Gaupp, C Hughes, GC Kopen and DG Phinney. (2003). Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection. J Cell Biochem 89:1235-1249.
23. Solchaga LA, K Penick, JD Porter, VM Goldberg, AI Caplan and JF Welter. (2005). FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrow-derived mesenchymal stem cells. J Cell Physiol 203:398-409.
24. Chiou M, Y Xu and MT Longaker. (2006). Mitogenic and chondrogenic effects of fibroblast growth factor-2 in adipose-derived mesenchymal cells. Biochem Biophys Res Commun 343:644-652.
25. Cohen ED, Z Wang, JJ Lepore, MM Lu, MM Taketo, DJ Epstein and EE Morrisey. (2007). Wnt/beta-catenin signaling promotes expansion of Isl-1-positive cardiac progenitor cells through regulation of FGF signaling. J Clin Invest 117:1794-1804.
26. Ito T, R Sawada, Y Fujiwara, Y Seyama and T Tsuchiya. (2007). FGF-2 suppresses cellular senescence of human mesenchymal stem cells by down-regulation of TGF-beta2. Biochem Biophys Res Commun 359:108-114.
27. Quarto N and MT Longaker. (2006). FGF-2 inhibits osteogenesis in mouse adipose tissue-derived stromal cells and sustains their proliferative and osteogenic potential state. Tissue Eng 12:1405-1418.
28. Kosaka N, M Kodama, H Sasaki, Y Yamamoto, F Takeshita, Y Takahama, H Sakamoto, T Kato, M Terada and T Ochiya. (2006). FGF-4 regulates neural progenitor cell proliferation and neuronal differentiation. FASEB J 20:1484-1485.
29. Yang W, LD Klaman, B Chen, T Araki, H Harada, SM Thomas, EL George and BG Neel. (2006). An Shp2/SFK/Ras/Erk signaling pathway controls trophoblast stem cell survival. Dev Cell 10:317-327.
30. Kouhara H, YR Hadari, T Spivak-Kroizman, J Schilling, D Bar-Sagi, I Lax and J Schlessinger. (1997). A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras/ MAPK signaling pathway. Cell 89:693-702.
31. Schlessinger J. (2004).Common and distinct elements in cellular signaling via EGF and FGF receptors. Science 306:1506-1507.
32. Dvorak P, D Dvorakova and A Hampl. (2006). Fibroblast growth factor signaling in embryonic and cancer stem cells. FEBS Lett 580:2869-2874.
33. Hill CS, J Wynne and R Treisman. (1994). Serum-regulated transcription by serum response factor (SRF): a novel role for the DNA binding domain. EMBO J 13:5421-5432.
34. Chang L and M Karin. (2001). Mammalian MAP kinase signalling cascades. Nature 410:37-40.
35. Shaulian E and M Karin. (2001). AP-1 in cell proliferation and survival. Oncogene 20:2390-2400.
36. Shaulian E and M Karin. (2002). AP-1 as a regulator of cell life and death. Nat Cell Biol 4(5):E131-136.
37. Wieczorek G, C Steinhoff, R Schulz, M Scheller, M Vingron, HH Ropers and UA Nuber. (2003). Gene expression profile of mouse bone marrow stromal cells determined by cDNA microarray analysis. Cell Tissue Res 311:227-237.
38. Kinnaird T, E Stabile, MS Burnett, M Shou, CW Lee, S Barr, S Fuchs and SE Epstein. (2004). Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 109:1543-1549.
39. Yoon J, WJ Shim, YM Ro and DS Lim. (2005). Transdifferentiation of mesenchymal stem cells into cardiomyocytes by direct cell-to-cell contact with neonatal cardiomyocyte but not adult cardiomyocytes. Ann Hematol 84:715-721.
40. Hess J, P Angel and M Schorpp-Kistner. (2004). AP-1 subunits: quarrel and harmony among siblings. J Cell Sci 117:5965-5973.
41. Cowling VH and MD Cole. (2006). Mechanism of transcriptional activation by the Myc oncoproteins. Semin Cancer Biol 16:242-252.
42. Raman M, W Chen and MH Cobb. (2007). Differential regulation and properties of MAPKs. Oncogene 26:3100-3112.
43. Makino S, K Fukuda, S Miyoshi, F Konishi, H Kodama, J Pan, M Sano, T Takahashi, S Hori, H Abe, J Hata, A Umezawa and S Ogawa. (1999). Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 103:697-705.
44. Woodbury D, EJ Schwarz, DJ Prockop and IB Black. (2000). Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 61:364-370.
45. Tremain N, J Korkko, D Ibberson, GC Kopen, C DiGirolamo and DG Phinney. (2001). MicroSAGE analysis of 2,353 expressed genes in a single cell-derived colony of undifferentiated human mesenchymal stem cells reveals mRNAs of multiple cell lineages. Stem Cells 19:408-418.
46. Mangi AA, N Noiseux, D Kong, H He, M Rezvani, JS Ingwall and VJ Dzau. (2003). Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 9:1195-1201.
47. Asakura A, P Seale, A Girgis-Gabardo and MA Rudnicki. (2002). Myogenic specification of side population cells in skeletal muscle. J Cell Biol 159:123-134.
48. Dekel B, L Zangi, E Shezen, S Reich-Zeliger, S Eventov-Friedman, H Katchman, J Jacob-Hirsch, N Amariglio, G Rechavi, R Margalit and Y Reisner. (2006). Isolation and characterization of nontubular sca-1+lin- multipotent stem/progenitor cells from adult mouse kidney. J Am Soc Nephrol 17:3300-3314.
49. Lapidot T and I Petit. (2002). Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp Hematol 30:973-981.
50. Moore MA. (2002). Cytokine and chemokine networks influencing stem cell proliferation, differentiation, and marrow homing. J Cell Biochem Suppl 38:29-38.
51. Nervi B, DC Link and JF DiPersio. (2006). Cytokines and hematopoietic stem cell mobilization. J Cell Biochem 99:690-705.
52. Manning BD and LC Cantley. (2007). AKT/PKB signaling: navigating downstream. Cell 129:1261-1274.
53. Datta SR, A Brunet and ME Greenberg. (1999). Cellular survival: a play in three Akts. Genes Dev 13:2905-2927.
54. Vlahos CJ, WF Matter, KY Hui and RF Brown. (1994). A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4- one (LY294002). J Biol Chem 269:5241-5248.
55. Learish RD, MD Bruss and M Haak-Frendscho. (2000). Inhibition of mitogen-activated protein kinase kinase blocks proliferation of neural progenitor cells. Brain Res Dev Brain Res 122:97-109.
56. Jin L, X Hu and L Feng. (2005). NT3 inhibits FGF2-induced neural progenitor cell proliferation via the PI3K/GSK3 pathway. J Neurochem 93:1251-1261.
57. Zaragosi LE, G Ailhaud and C Dani. (2006). Autocrine fibroblast growth factor 2 signaling is critical for self-renewal of human multipotent adipose-derived stem cells. Stem Cells 24:2412-2419.
58. Bobick BE, TM Thornhill and WM Kulyk. (2007). Fibroblast growth factors 2, 4, and 8 exert both negative and positive effects on limb, frontonasal, and mandibular chondrogenesis via MEK-ERK activation. J Cell Physiol 211:233-243.
59. Karin M. (1995). The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 270:16483-16486.
60. Karin M, Z Liu and E Zandi. (1997). AP-1 function and regulation. Curr Opin Cell Biol 9:240-246.
61. Kang HB, JS Kim, HJ Kwon, KH Nam, HS Youn, DE Sok and Y Lee. (2005). Basic fibroblast growth factor activates ERK and induces c-fos in human embryonic stem cell line MizhES1. Stem Cells Dev 14:395-401.
62. Szabowski A, N Maas-Szabowski, S Andrecht, A Kolbus, M Schorpp-Kistner, NE Fusenig and P Angel. (2000). c-Jun and JunB antagonistically control cytokine-regulated mesenchymal-epidermal interaction in skin. Cell 103:745-755.
63. Schöthal A, M Bücher, P Angel, HJ Rahmsdorf, H Ponta, K Hattori, R Chiu, M Karin and P Herrlich. (1989). The Fos and Jun/AP-1 proteins are involved in the downregulation of Fos transcription. Oncogene 4:629-636.
64. Angel P, K Hattori, T Smeal and M Karin. (1988). The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1. Cell 55:875-885.
65. Rommel C, BA Clarke, S Zimmermann, L Nunez, R Rossman, K Reid, K Moelling, GD Yancopoulos and DJ Glass. (1999). Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt. Science 286:1738-1741.
66. Zimmermann S and K Moelling. (1999). Phosphorylation and regulation of Raf by Akt (protein kinase B). Science 286:1741-1744.
67. Kim AH, G Khursigara, X Sun, TF Franke and MV Chao. (2001). Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase 1. Mol Cell Biol 21:893-901.
68. Deo DD, TW Axelrad, EG Robert, V Marcheselli, NG Bazan and JD Hunt. (2002). Phosphorylation of STAT-3 in response to basic fibroblast growth factor occurs through a mechanism involving platelet-activating factor, JAK-2, and Src in human umbilical vein endothelial cells. Evidence for a dual kinase mechanism. J Biol Chem 277:21237-21245.